Severe rotavirus gastroenteritis in children older than 5 years after vaccine introduction

Kiyoshi Kyo1, Chika Takano2, Yuki Kasuga1

  • 1Department of Pediatrics and Child Health, Nihon University School of Medicine, 30-1, Oyaguchikamicho, Itabashi-ku, Tokyo, 173-8610, Japan.

Insights

Rotavirus (RV) gastroenteritis remains a concern, with increasing hospitalizations in children over 5 years old. Vaccination appears to reduce symptom severity in this age group, highlighting the need for continued monitoring.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Background:

  • Rotavirus (RV) is a primary cause of acute gastroenteritis in infants.
  • While RV vaccines have reduced severe infections, a notable burden persists, even in developed nations like Japan.
  • Understanding RV epidemiology and vaccine effectiveness is crucial for public health strategies.

Purpose of the Study:

  • To analyze trends in severe rotavirus gastroenteritis hospitalizations in Japan.
  • To evaluate the efficacy of the rotavirus vaccine in children older than 5 years.
  • To identify prevalent rotavirus genotypes circulating in Japan.

Main Methods:

  • Retrospective survey of 380 hospitalized acute gastroenteritis patients (2015-2019).
  • Detailed clinical data collected for 21 RV gastroenteritis patients in 2019.
  • Fecal sample analysis to determine RV genotypes (G9P[8]I1 identified).

Main Results:

  • An increasing trend in hospitalizations for severe RV gastroenteritis was observed in children over 5 years old.
  • Vaccinated patients aged ≥5 years showed significantly less severe gastrointestinal symptoms compared to unvaccinated patients (p=0.014).
  • The predominant RV genotype identified in 2019 was G9P[8]I1.

Conclusions:

  • Children over 5 years old are susceptible to severe rotavirus infections, necessitating prompt intervention strategies.
  • Continuous monitoring of clinical characteristics and RV epidemiology is essential following the inclusion of RV vaccines in Japan's national immunization program.
  • Vaccine effectiveness in older age groups warrants further investigation and surveillance.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
49.4K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
262
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
250
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
401
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
399